Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00131469
Status:
COMPLETED
Last Update Posted:
2019-04-24
First Post:
2005-08-16
Brief Title:
Study of Teriparatide FORTEO to Treat Adults With Osteogenesis Imperfecta
Sponsor:
Oregon Health and Science University
Organization:
Oregon Health and Science University
Organization Data
Organization:
Oregon Health and Science University
Class:
OTHER
Study ID:
IBMD-OI
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Oregon Health and Science University
Lead Sponsor Class:
OTHER
Responsible Party:
Eric Orwoll MD
Responsible Party Title:
Professor Of Medicine
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Oregon Health and Science University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Eli Lilly and Company | INDUSTRY |
| Osteogenesis Imperfecta Foundation | OTHER |
| National Institutes of Health NIH | NIH |
| National Center for Research Resources NCRR | NIH |